{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:16:20Z","timestamp":1770290180930,"version":"3.49.0"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.pcad.2021.02.008","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T23:14:23Z","timestamp":1613862863000},"page":"53-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Effects of statins on myocarditis: A review of underlying molecular mechanisms"],"prefix":"10.1016","volume":"67","author":[{"given":"Negin","family":"Parsamanesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Karami-Zarandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Penson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0005","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacl.2015.11.010","article-title":"A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality","volume":"10","author":"Wadhera","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.pcad.2021.02.008_bb0010","first-page":"256","article-title":"Jeremiah Metzger Lecture: cholesterol, inflammation and atherosclerotic cardiovascular disease: is it all LDL?","volume":"122","author":"Gotto","year":"2011","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"11","key":"10.1016\/j.pcad.2021.02.008_bb0015","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.7326\/0003-4819-8-11-1436","article-title":"Arteriosclerosis in diabetes: I. relationship between plasma cholesterol and arteriosclerosis. Ii. Effects of the high carbohydrate-low calorie diet","volume":"8","author":"Rabinowitch","year":"1935","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0002-8703(48)90646-2","article-title":"Hereditary disturbance of cholesterol metabolism: a factor in the genesis of atherosclerosis","volume":"35","author":"Boas","year":"1948","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0025","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archinte.1938.00180100024003","article-title":"Cholesterol content of the blood in heart disease","volume":"61","author":"Poindexter","year":"1938","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2021.02.008_bb0030","article-title":"Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms","volume":"105735","author":"Liberale","year":"2020","journal-title":"Int J Biochem Cell Biol"},{"issue":"5519","key":"10.1016\/j.pcad.2021.02.008_bb0035","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.pcad.2021.02.008_bb0040","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1073\/pnas.77.7.3957","article-title":"Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent","volume":"77","author":"Alberts","year":"1980","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.pcad.2021.02.008_bb0045","first-page":"1033","article-title":"Regulation of cholesterol synthesis, as focused on the regulation of HMG-CoA reductase (author's transl)","volume":"52","author":"Endo","year":"1980","journal-title":"Seikagaku J Jpn BiochemSoc"},{"key":"10.1016\/j.pcad.2021.02.008_bb0050","article-title":"Statins and autoimmunity: state-of-the-art","volume":"107614","author":"Dehnavi","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmed.2007.11.004","article-title":"Pleiotropic effects of statin therapy: molecular mechanisms and clinical results","volume":"14","author":"Wang","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.pcad.2021.02.008_bb0060","first-page":"30173","article-title":"Effects of statins on brain tumors: a review","volume":"S1044-579X","author":"Afshari","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/biof.1597","article-title":"The effects of statins on microglial cells to protect against neurodegenerative disorders: a mechanistic review","volume":"46","author":"Bagheri","year":"2020","journal-title":"BioFactors"},{"key":"10.1016\/j.pcad.2021.02.008_bb0070","doi-asserted-by":"crossref","unstructured":"Kouhpeikar H, Delbari Z, Sathyapalan T, Simental-Mend\u00eda LE, Jamialahmadi T, Sahebkar A. The effect of statins through mast cells in the pathophysiology of atherosclerosis: a review. Curr Atheroscler Rep. 2020;22(5).","DOI":"10.1007\/s11883-020-00837-9"},{"key":"10.1016\/j.pcad.2021.02.008_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12654","article-title":"Effects of statins on mitochondrial pathways","author":"Mollazadeh","year":"2021","journal-title":"J Cachexia Sarcop Muscl"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0080","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1160\/th15-08-0620","article-title":"The impact of statin therapy on plasma levels of von Willebrand factor antigen: systematic review and meta-analysis of randomised placebo-controlled trials","volume":"115","author":"Sahebkar","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pcad.2021.02.008_bb0085","doi-asserted-by":"crossref","first-page":"101054","DOI":"10.1016\/j.plipres.2020.101054","article-title":"Antiviral effects of statins","volume":"79","author":"Gorabi","year":"2020","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.pcad.2021.02.008_bb0090","doi-asserted-by":"crossref","first-page":"107483","DOI":"10.1016\/j.pharmthera.2020.107483","article-title":"Antifungal effects of statins","volume":"208","author":"Tavakkoli","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pcad.2021.02.008_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-0711-11-13","article-title":"Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin","volume":"11","author":"Masadeh","year":"2012","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128098","article-title":"Statins and antimicrobial effects: simvastatin as a potential drug against Staphylococcus aureus biofilm","volume":"10","author":"Graziano","year":"2015","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217423","article-title":"A possible association between statin use and improved clostridioides difficile infection mortality in veterans","volume":"14","author":"Argamany","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.pcad.2021.02.008_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7617023","article-title":"Potential effect of statins on Mycobacterium tuberculosis infection","volume":"2018","author":"Guerra-De-Blas","year":"2018","journal-title":"J Immunol Res"},{"issue":"8","key":"10.1016\/j.pcad.2021.02.008_bb0115","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/CIRCRESAHA.107.161307","article-title":"Simvastatin reduces Chlamydophila pneumoniae\u2013mediated histone modifications and gene expression in cultured human endothelial cells","volume":"102","author":"Schmeck","year":"2008","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.pcad.2021.02.008_bb0120","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/AAC.01330-06","article-title":"Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum","volume":"51","author":"Pradines","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1574-6968.2006.00370.x","article-title":"Growth inhibition of Candida species and Aspergillus fumigatus by statins","volume":"262","author":"Macreadie","year":"2006","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.22916","article-title":"Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development","volume":"50","author":"Delang","year":"2009","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.pcad.2021.02.008_bb0135","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1073\/pnas.0305149101","article-title":"Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas","volume":"101","author":"Katano","year":"2004","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0140","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/FJC.0b013e3181f6b28d","article-title":"Atorvastatin attenuates Coxsackie virus B3m-induced viral myocarditis in mice","volume":"56","author":"Guan","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.008_bb0145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.326","article-title":"The group B coxsackieviruses and myocarditis","volume":"11","author":"Kim","year":"2001","journal-title":"Rev Med Virol"},{"issue":"8","key":"10.1016\/j.pcad.2021.02.008_bb0150","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0735-1097(02)01776-X","article-title":"Role of Fas\/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3","volume":"39","author":"Seko","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2021.02.008_bb0155","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.4049\/jimmunol.170.12.6209","article-title":"Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages","volume":"170","author":"Park","year":"2003","journal-title":"J Immunol"},{"issue":"14","key":"10.1016\/j.pcad.2021.02.008_bb0160","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2174\/1389450120666190618124722","article-title":"Advancement of mechanisms of coxsackie virus B3-induced myocarditis pathogenesis and the potential therapeutic targets","volume":"20","author":"Daba","year":"2019","journal-title":"Curr Drug Targets"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0165","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.18632\/oncotarget.3073","article-title":"Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.pcad.2021.02.008_bb0170","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2021.02.008_bb0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fpsyt.2019.00103","article-title":"Statins and inflammation: new therapeutic opportunities in psychiatry","volume":"10","author":"Kim","year":"2019","journal-title":"Front Psych"},{"issue":"46","key":"10.1016\/j.pcad.2021.02.008_bb0185","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.2174\/1381612823666171009141201","article-title":"Statins and inflammation in cardiovascular disease","volume":"23","author":"Vogiatzi","year":"2017","journal-title":"Curr Pharm Des"},{"issue":"12","key":"10.1016\/j.pcad.2021.02.008_bb0190","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/jcm8122051","article-title":"Statin-induced nitric oxide signaling: mechanisms and therapeutic implications","volume":"8","author":"Gorabi","year":"2019","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0195","doi-asserted-by":"crossref","DOI":"10.18388\/abp.2017_2305","article-title":"Lower levels of Caveolin-1 and higher levels of endothelial nitric oxide synthase are observed in abdominal aortic aneurysm patients treated with simvastatin","volume":"65","author":"Kowalska","year":"2018","journal-title":"Acta Biochim Polonica"},{"key":"10.1016\/j.pcad.2021.02.008_bb0200","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/01.CIR.0000111128.83347.7A","article-title":"Differential modulation of caveolin-1 expression in cells of the vasculature by","volume":"109","author":"Plenz","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pcad.2021.02.008_bb0205","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pcad.2021.02.008_bb0210","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.biopha.2018.04.118","article-title":"Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin","volume":"103","author":"Mason","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0215","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/HCO.0b013e3283398e53","article-title":"Statins and inflammation: an update","volume":"25","author":"Quist-Paulsen","year":"2010","journal-title":"Curr Opin Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0220","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.bjp.0704070","article-title":"A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid","volume":"133","author":"Stalker","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1016\/j.pcad.2021.02.008_bb0225","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1006\/cyto.1996.0109","article-title":"Nitric oxide attenuates adhesion molecule expression in human endothelial cells","volume":"8","author":"Takahashi","year":"1996","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0230","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/138161209787315684","article-title":"Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy","volume":"15","author":"Zhou","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"11","key":"10.1016\/j.pcad.2021.02.008_bb0235","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3390\/ijms17111937","article-title":"The vitamin E analog gamma-tocotrienol (GT3) and statins synergistically up-regulate endothelial thrombomodulin (TM)","volume":"17","author":"Pathak","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.pcad.2021.02.008_bb0240","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/hq0801.094222","article-title":"In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products","volume":"21","author":"Diomede","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.008_bb0245","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/FJC.0000000000000147","article-title":"Statin inhibits the expression of secretory phospholipase A2 and subsequent monocyte chemoattractant protein-1 in human endothelial cells","volume":"64","author":"Sonoki","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/imm.12902","article-title":"Immune modulatory effects of statins","volume":"154","author":"Zeiser","year":"2018","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0255","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/2211-5463.12854","article-title":"Interferon-\u03b3-induced HLA Class II expression on endothelial cells is decreased by inhibition of mTOR and HMG-CoA reductase","volume":"10","author":"Maenaka","year":"2020","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.pcad.2021.02.008_bb0260","first-page":"RV17001","article-title":"Role of NLRP3 inflammasomes in atherosclerosis","author":"Karasawa","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.pcad.2021.02.008_bb0265","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.phrs.2018.08.014","article-title":"Effect of statins on toll-like receptors: a new insight to pleiotropic effects","volume":"135","author":"Bahrami","year":"2018","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0270","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3349\/ymj.2016.57.1.5","article-title":"NOD-like receptors in infection, immunity, and diseases","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med J"},{"issue":"9","key":"10.1016\/j.pcad.2021.02.008_bb0275","doi-asserted-by":"crossref","first-page":"15746","DOI":"10.1002\/jcb.28844","article-title":"V617F-independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease","volume":"120","author":"Asadzadeh-Aghdaei","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.pcad.2021.02.008_bb0280","series-title":"Seminars in Immunology","article-title":"The NLRP3 inflammasome: a sensor of immune danger signals","year":"2009"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0285","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clim.2009.07.016","article-title":"Innate immune signals in atherosclerosis","volume":"134","author":"Lundberg","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.pcad.2021.02.008_bb0290","article-title":"Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways","author":"Koushki","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0295","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/jcm8010118","article-title":"Effect of statin therapy on arterial wall inflammation based on 18F-FDG PET\/CT: a systematic review and meta-analysis of interventional studies","volume":"8","author":"Pirro","year":"2019","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0300","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.111.004994","article-title":"Pharmacological actions of statins: a critical appraisal in the management of cancer","volume":"64","author":"Gazzerro","year":"2012","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.008_bb0305","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1067\/mhj.2002.130300","article-title":"Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase","volume":"144","author":"Istvan","year":"2002","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0310","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10409238.2019.1568964","article-title":"Inhibition of farnesyl pyrophosphate (FPP) and\/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers","volume":"54","author":"Waller","year":"2019","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.pcad.2021.02.008_bb0315","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fcell.2019.00006","article-title":"Statins and histone deacetylase inhibitors affect lamin A\/C\u2013histone deacetylase 2 interaction in human cells","volume":"7","author":"Mattioli","year":"2019","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0320","doi-asserted-by":"crossref","first-page":"C661","DOI":"10.1152\/ajpcell.00459.2005","article-title":"Physiological role of ROCKs in the cardiovascular system","volume":"290","author":"Noma","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0325","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.108.813311","article-title":"Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation","volume":"119","author":"Liu","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.008_bb0330","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/HJH.0b013e328340902d","article-title":"Calcium channel blocker and Rho-associated kinase activity in patients with hypertension","volume":"29","author":"Hata","year":"2011","journal-title":"J Hypertens"},{"issue":"10","key":"10.1016\/j.pcad.2021.02.008_bb0335","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1253\/circj.CJ-13-0397","article-title":"Rho-kinase activation in patients with heart failure","volume":"77","author":"Fukumoto","year":"2013","journal-title":"Circ J"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0340","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ahj.2011.01.024","article-title":"Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure","volume":"161","author":"Ocaranza","year":"2011","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.008_bb0345","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.toxlet.2012.03.006","article-title":"Inhibition of rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-\u03b21\u2013TAK1","volume":"211","author":"Li","year":"2012","journal-title":"Toxicol Lett"},{"issue":"18","key":"10.1016\/j.pcad.2021.02.008_bb0350","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1161\/01.CIR.0000127939.16111.58","article-title":"Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice","volume":"109","author":"Hattori","year":"2004","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0355","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.yjmcc.2008.01.011","article-title":"Small GTP-binding proteins and their regulators in cardiac hypertrophy","volume":"44","author":"Lezoualc\u2019h","year":"2008","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.008_bb0360","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jcp.21094","article-title":"Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses","volume":"212","author":"Clerk","year":"2007","journal-title":"J Cell Physiol"},{"issue":"1\u20132","key":"10.1016\/j.pcad.2021.02.008_bb0365","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vph.2012.10.003","article-title":"Recent development in the effects of statins on cardiovascular disease through Rac1 and NADPH oxidase","volume":"58","author":"Kwok","year":"2013","journal-title":"Vascul Pharmacol"},{"issue":"46","key":"10.1016\/j.pcad.2021.02.008_bb0370","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.2174\/1381612823666170926130338","article-title":"Statins and oxidative stress in the cardiovascular system","volume":"23","author":"Margaritis","year":"2017","journal-title":"Curr Pharm Des"},{"issue":"10","key":"10.1016\/j.pcad.2021.02.008_bb0375","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1161\/01.ATV.15.10.1652","article-title":"Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia","volume":"15","author":"Gauthier","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.pcad.2021.02.008_bb0380","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.pcad.2021.02.008_bb0385","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1634\/stemcells.2006-0753","article-title":"Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation","volume":"25","author":"Lee","year":"2007","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.008_bb0390","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2010.04.117","article-title":"Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K\/Akt pathway","volume":"396","author":"Chartoumpekis","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"29","key":"10.1016\/j.pcad.2021.02.008_bb0395","doi-asserted-by":"crossref","first-page":"46219","DOI":"10.18632\/oncotarget.10078","article-title":"Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2) activation through ERK and PI3K\/Akt pathway in colon cancer","volume":"7","author":"Jang","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.008_bb0400","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2010.07.059","article-title":"Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway","volume":"213","author":"Makabe","year":"2010","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0405","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/ndt\/gfg538","article-title":"Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study","volume":"19","author":"Osende","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.pcad.2021.02.008_bb0410","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/eurheartj\/ehr224","article-title":"Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a \u201cmitohormesis\u201d mechanism involving reactive oxygen species and PGC-1","volume":"33","author":"Bouitbir","year":"2012","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0415","first-page":"31","article-title":"Statins, fibrates, and other peroxisome proliferator-activated receptor agonists for the treatment of cholestatic liver diseases","volume":"16","author":"Dubrovsky","year":"2020","journal-title":"Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0420","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.RES.0000202706.70992.95","article-title":"Acute antiinflammatory properties of statins involve peroxisome proliferator\u2013activated receptor-\u03b1 via inhibition of the protein kinase C signaling pathway","volume":"98","author":"Paumelle","year":"2006","journal-title":"Circ Res"},{"issue":"1\u20133","key":"10.1016\/j.pcad.2021.02.008_bb0425","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejphar.2010.08.058","article-title":"Simvastatin attenuates cardiopulmonary bypass-induced myocardial inflammatory injury in rats by activating peroxisome proliferator-activated receptor \u03b3","volume":"649","author":"Shen","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0430","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.metabol.2015.11.007","article-title":"Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-\u03b3)","volume":"65","author":"Chen","year":"2016","journal-title":"Metab Clin Exp"},{"issue":"9","key":"10.1016\/j.pcad.2021.02.008_bb0435","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/hc3401.095198","article-title":"Advances in the understanding of myocarditis","volume":"104","author":"Liu","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0440","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0735-1097(89)90465-8","article-title":"Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis","volume":"14","author":"Chow","year":"1989","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0445","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCULATIONAHA.105.589663","article-title":"Diagnosis of myocarditis: death of Dallas criteria","volume":"113","author":"Baughman","year":"2006","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.pcad.2021.02.008_bb0450","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1056\/NEJM200011093431908","article-title":"Myocarditis","volume":"343","author":"Feldman","year":"2000","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.pcad.2021.02.008_bb0455","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.jacc.2007.09.008","volume":"50","author":"Cooper","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.pcad.2021.02.008_bb0460","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","article-title":"High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201cidiopathic\u201d left ventricular dysfunction","volume":"111","author":"K\u00fchl","year":"2005","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.pcad.2021.02.008_bb0465","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.105.606509","article-title":"Clinical perspective","volume":"114","author":"Mahrholdt","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0470","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cardfail.2005.11.004","article-title":"Myocarditis and heart failure associated with hepatitis C virus infection","volume":"12","author":"Matsumori","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.pcad.2021.02.008_bb0475","first-page":"144","article-title":"Hepatitis C virus infection and cardiomyopathies","volume":"96","author":"Matsumori","year":"2005","journal-title":"Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0480","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0735-1097(94)90865-6","article-title":"Mycarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus","volume":"24","author":"Herskowitz","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2021.02.008_bb0485","first-page":"395","article-title":"Dilated cardiomyopathy in two adult human immunodeficiency positive (HIV+) patients possibly related to highly active antiretroviral therapy (HAART)","volume":"10","author":"Breuckmann","year":"2005","journal-title":"Eur J Med Res"},{"issue":"11","key":"10.1016\/j.pcad.2021.02.008_bb0490","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/08892220260139512","article-title":"HIV type 1 glycoprotein 120 inhibits cardiac myocyte contraction","volume":"18","author":"Chen","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"10","key":"10.1016\/j.pcad.2021.02.008_bb0495","first-page":"943","article-title":"Pathology of the heart in acquired immunodeficiency syndrome","volume":"111","author":"Roldan","year":"1987","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0500","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.2001.tb03912.x","article-title":"Drugs and cardiotoxicity in HIV and AIDS","volume":"946","author":"Fantoni","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"15","key":"10.1016\/j.pcad.2021.02.008_bb0505","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMra0800028","article-title":"Myocarditis","volume":"360","author":"Cooper","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0510","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4269\/ajtmh.1997.56.485","article-title":"Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis","volume":"56","author":"de Lourdes","year":"1997","journal-title":"Am J Trop Med Hyg"},{"issue":"706","key":"10.1016\/j.pcad.2021.02.008_bb0515","first-page":"23","article-title":"Parasitic diseases of the heart","volume":"9","author":"Kirchhoff","year":"2004","journal-title":"Front Biosci"},{"issue":"11","key":"10.1016\/j.pcad.2021.02.008_bb0520","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/rheumatology\/ken329","article-title":"Vasa-vasoritis of the aorta and fatal myocarditis in fulminant Churg\u2013Strauss syndrome","volume":"47","author":"Hervier","year":"2008","journal-title":"Rheumatology"},{"issue":"22","key":"10.1016\/j.pcad.2021.02.008_bb0525","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1161\/01.CIR.0000017880.86166.87","article-title":"Celiac disease associated with autoimmune myocarditis","volume":"105","author":"Frustaci","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0530","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000006923","article-title":"L\u00f6ffler\u2019s endomyocarditis in the idiopathic hypereosinophilic syndrome","volume":"91","author":"Corssmit","year":"1999","journal-title":"Cardiology"},{"key":"10.1016\/j.pcad.2021.02.008_bb0535","series-title":"Mayo Clinic Proceedings","article-title":"Acute myocarditis associated with tetanus vaccination","year":"2003"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.008_bb0540","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/hrt.37.2.192","article-title":"Idiopathic giant cell myocarditis--a distinctive clinico-pathological entity","volume":"37","author":"Davies","year":"1975","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0545","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/clc.4960210109","article-title":"A case of giant cell myocarditis and malignant thymoma: a postmortem diagnosis by needle biopsy","volume":"21","author":"Kilgallen","year":"1998","journal-title":"Clin Cardiol"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0550","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1054-8807(00)00049-1","article-title":"Giant cell myocarditis as a manifestation of drug hypersensitivity","volume":"9","author":"Daniels","year":"2000","journal-title":"Cardiovasc Pathol"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.008_bb0555","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0735-1097(02)02715-8","article-title":"A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis","volume":"41","author":"Okura","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0560","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9149(98)00377-4","article-title":"Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy","volume":"82","author":"Yazaki","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2021.02.008_bb0565","series-title":"Seminars in Oncology","article-title":"Anthracycline-induced cardiomyopathy","year":"2001"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0570","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF03256574","article-title":"Cocaine cardiotoxicity","volume":"9","author":"Phillips","year":"2009","journal-title":"Am J Cardiovasc Drugs"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0575","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.pcad.2009.11.006","article-title":"Myocarditis","volume":"52","author":"Blauwet","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"issue":"10","key":"10.1016\/j.pcad.2021.02.008_bb0580","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1089\/dna.2020.5703","article-title":"The novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic options","volume":"39","author":"Asghari","year":"2020","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.pcad.2021.02.008_bb0585","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.pcad.2021.02.008_bb0590","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2021.02.008_bb0595","doi-asserted-by":"crossref","first-page":"1547e5","DOI":"10.1016\/j.ajem.2020.04.080","article-title":"COVID-19 myopericarditis: it should be kept in mind in today\u2019s conditions","volume":"38","author":"Cizgici","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.pcad.2021.02.008_bb0600","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/CIRCULATIONAHA.120.047164","article-title":"The variety of cardiovascular presentations of COVID-19","volume":"141","author":"Fried","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pcad.2021.02.008_bb0605","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0002-9149(84)90089-4","article-title":"Echocardiography in acute infectious myocarditis: relation to clinical and electrocardiographic findings","volume":"53","author":"Nieminen","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2021.02.008_bb0610","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2021.02.008_bb0615","article-title":"First case of COVID-19 complicated with fulminant myocarditis: a case report and insights","volume":"1","author":"Zeng","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.pcad.2021.02.008_bb0620","article-title":"Systematic review of COVID-19 related myocarditis: insights on management and outcome","author":"Sawalha","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.008_bb0625","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.hrtlng.2020.08.013","article-title":"Coronavirus-induced myocarditis: a meta-summary of cases","volume":"49","author":"Ho","year":"2020","journal-title":"Heart Lung"},{"issue":"24","key":"10.1016\/j.pcad.2021.02.008_bb0630","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1093\/eurheartj\/ehm456","volume":"28","author":"Cooper","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2021.02.008_bb0635","first-page":"1","article-title":"Neurological manifestations of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19","author":"Parsamanesh","year":"2020","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.pcad.2021.02.008_bb0640","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/0003319720952284","article-title":"Interaction between coronavirus S-protein and human ACE2: hints for exploring efficient therapeutic targets to treat COVID-19","volume":"72","author":"Momtazi-Borojeni","year":"2020","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0645","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1465-9921-6-42","article-title":"Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS","volume":"6","author":"Wang","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.pcad.2021.02.008_bb0650","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19\u2014immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.008_bb0655","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12016-020-08798-2","article-title":"Type I interferons in the pathogenesis and treatment of autoimmune diseases","volume":"59","author":"Jiang","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"10.1016\/j.pcad.2021.02.008_bb0660","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.lfs.2006.11.045","article-title":"Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization","volume":"80","author":"Tang","year":"2007","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0665","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1440-1711.2006.01430.x","article-title":"Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats","volume":"84","author":"Li","year":"2006","journal-title":"Immunol Cell Biol"},{"issue":"11","key":"10.1016\/j.pcad.2021.02.008_bb0670","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.tips.2018.09.005","article-title":"MicroRNAs: novel molecular targets and response modulators of statin therapy","volume":"39","author":"Mohajeri","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0675","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.4049\/jimmunol.170.3.1150","article-title":"Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes","volume":"170","author":"Otten","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.008_bb0680","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2003.11.004","article-title":"Fluvastatin inhibits raft dependent Fc\u03b3 receptor signalling in human monocytes","volume":"172","author":"Hillyard","year":"2004","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0685","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00011-013-0695-z","article-title":"Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells","volume":"63","author":"Werner","year":"2014","journal-title":"Inflamm Res"},{"issue":"6911","key":"10.1016\/j.pcad.2021.02.008_bb0690","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0695","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.4049\/jimmunol.174.4.2327","article-title":"Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction","volume":"174","author":"Gegg","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0700","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.170.3.1524","article-title":"A novel anti-inflammatory role for simvastatin in inflammatory arthritis","volume":"170","author":"Leung","year":"2003","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.pcad.2021.02.008_bb0705","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5414\/CPP41397","article-title":"Statins differ in their ability to block NF-kappaB activation in human blood monocytes","volume":"41","author":"Hilgendorff","year":"2003","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0710","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cardiores.2004.09.014","article-title":"HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation","volume":"64","author":"Azuma","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0715","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/75068","article-title":"Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo","volume":"6","author":"Atreya","year":"2000","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.008_bb0720","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.CIR.0000043802.38699.66","article-title":"Interleukin-6\u2013deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3","volume":"107","author":"Eriksson","year":"2003","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.pcad.2021.02.008_bb0725","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.0000084539.58092.DE","article-title":"Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy","volume":"108","author":"Node","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pcad.2021.02.008_bb0730","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1161\/hh2201.099373","article-title":"cis Element decoy against nuclear factor-\u03baB attenuates development of experimental autoimmune myocarditis in rats","volume":"89","author":"Yokoseki","year":"2001","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0735","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10557-013-6464-y","article-title":"Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice","volume":"27","author":"Tajiri","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pcad.2021.02.008_bb0740","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2016.07.182","article-title":"Native T1 and T2 mapping by CMR in lupus myocarditis: disease recognition and response to treatment","volume":"222","author":"Hinojar","year":"2016","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0745","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cardiores.2004.01.018","article-title":"The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model","volume":"62","author":"Kumagai","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"16","key":"10.1016\/j.pcad.2021.02.008_bb0750","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000145163.56529.D1","article-title":"Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs","volume":"110","author":"Shiroshita-Takeshita","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0755","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1253\/circj.70.605","article-title":"Tumor necrosis factor-\u03b1 downregulates the voltage gated outward K+ current in cultured neonatal rat Cardiomyocytes","volume":"70","author":"Kawada","year":"2006","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0760","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/jaut.1998.0273","article-title":"Cardiac dysfunction in murine autoimmune myocarditis","volume":"12","author":"Less","year":"1999","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.pcad.2021.02.008_bb0765","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10557-012-6372-6","article-title":"Effects of HMG-CoA reductase inhibitor on experimental autoimmune myocarditis","volume":"26","author":"Liu","year":"2012","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0770","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.CIR.0000136088.18960.E6","article-title":"Statins inhibit \u03b2-adrenergic receptor\u2013stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism","volume":"110","author":"Ito","year":"2004","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pcad.2021.02.008_bb0775","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI29134","article-title":"TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways","volume":"117","author":"Haudek","year":"2007","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.008_bb0780","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.yjmcc.2008.03.016","article-title":"Amelioration of myocarditis by statin through inhibiting cross-talk between antigen presenting cells and lymphocytes in rats","volume":"44","author":"Wu","year":"2008","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0785","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00005344-200403000-00018","article-title":"Simvastatin preserves cardiac function in genetically determined cardiomyopathy","volume":"43","author":"Abraham","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0790","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.yjmcc.2004.05.025","article-title":"Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3\u03b2 and transcription factor \u03b2-catenin","volume":"37","author":"Bergmann","year":"2004","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0795","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5144\/0256-4947.2016.78","article-title":"Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus","volume":"36","author":"Alhogbani","year":"2016","journal-title":"Ann Saudi Med"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0800","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.pcad.2021.02.008_bb0805","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ejhf.1828","article-title":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock","volume":"22","author":"Tavazzi","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pcad.2021.02.008_bb0810","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2021.02.008_bb0815","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/eurheartj\/ehaa190","article-title":"Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin","volume":"42","author":"Hu","year":"2020","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.pcad.2021.02.008_bb0820","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.pcad.2021.02.008_bb0825","article-title":"SARS-CoV-2 and cardiovascular complications: from molecular mechanisms to pharmaceutical management","volume":"114114","author":"Wu","year":"2020","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0830","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5114\/aoms.2020.94655","article-title":"Statins and the COVID-19 main protease: in silico evidence on direct interaction","volume":"16","author":"Reiner","year":"2020","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.pcad.2021.02.008_bb0835","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.pcad.2021.02.008_bb0840","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.pcad.2021.02.008_bb0845","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5114\/aoms.2020.94503","article-title":"Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic","volume":"16","author":"Katsiki","year":"2020","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.pcad.2021.02.008_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154375","article-title":"Commentary: statins, COVID-19, and coronary artery disease: killing two birds with one stone","volume":"113","author":"Ganjali","year":"2020","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.pcad.2021.02.008_bb0855","first-page":"278","article-title":"Statins in COVID-19: is there any foundation?","volume":"32","author":"Mart\u00ednez","year":"2020","journal-title":"Cl\u00edn Investig Arterioscler"},{"issue":"6","key":"10.1016\/j.pcad.2021.02.008_bb0860","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/jcm9061909","article-title":"Cholesterol in relation to COVID-19: should we care about it?","volume":"9","author":"Radenkovic","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0865","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00011-009-0093-8","article-title":"Immunomodulation by atorvastatin upregulates expression of gap junction proteins in coxsackievirus B3 (CVB3)-induced myocarditis","volume":"59","author":"Zhang","year":"2010","journal-title":"Inflamm Res"},{"issue":"4","key":"10.1016\/j.pcad.2021.02.008_bb0870","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaut.2005.06.005","article-title":"Effects of atorvastatin on the Th1\/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats","volume":"25","author":"Liu","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.pcad.2021.02.008_bb6000","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1038\/srep09902","article-title":"A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations","volume":"13(5)","author":"Serban","year":"2015","journal-title":"Sci Rep."}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062021000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062021000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:19:12Z","timestamp":1758500352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062021000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":175,"alternative-id":["S0033062021000220"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2021.02.008","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of statins on myocarditis: A review of underlying molecular mechanisms","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2021.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}